These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 16186797

  • 1. A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis.
    Jacquel A, Herrant M, Defamie V, Belhacene N, Colosetti P, Marchetti S, Legros L, Deckert M, Mari B, Cassuto JP, Hofman P, Auberger P.
    Oncogene; 2006 Feb 02; 25(5):781-94. PubMed ID: 16186797
    [Abstract] [Full Text] [Related]

  • 2. Membrane type sialidase inhibits the megakaryocytic differentiation of human leukemia K562 cells.
    Jin UH, Ha KT, Kim KW, Chang YC, Lee YC, Ko JH, Kim CH.
    Biochim Biophys Acta; 2008 May 02; 1780(5):757-63. PubMed ID: 18339327
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells.
    Chou CC, Yung BY, Hsu CY.
    Life Sci; 2007 May 08; 80(22):2051-9. PubMed ID: 17448503
    [Abstract] [Full Text] [Related]

  • 6. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells.
    Kim KW, Kim SH, Lee EY, Kim ND, Kang HS, Kim HD, Chung BS, Kang CD.
    J Biol Chem; 2001 Apr 20; 276(16):13186-91. PubMed ID: 11278385
    [Abstract] [Full Text] [Related]

  • 7. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S, Bertolette D, Petrow-Sadowski C, Ruscetti FW.
    Platelets; 2007 Dec 20; 18(8):566-78. PubMed ID: 18041647
    [Abstract] [Full Text] [Related]

  • 8. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells.
    Herrera R, Hubbell S, Decker S, Petruzzelli L.
    Exp Cell Res; 1998 Feb 01; 238(2):407-14. PubMed ID: 9473349
    [Abstract] [Full Text] [Related]

  • 9. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation.
    Shelly C, Petruzzelli L, Herrera R.
    Cell Growth Differ; 2000 Sep 01; 11(9):501-6. PubMed ID: 11007455
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells.
    Kohmura K, Miyakawa Y, Kawai Y, Ikeda Y, Kizaki M.
    J Cell Physiol; 2004 Mar 01; 198(3):370-6. PubMed ID: 14755542
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cells.
    Chang YI, Hua WK, Yao CL, Hwang SM, Hung YC, Kuan CJ, Leou JS, Lin WJ.
    J Biol Chem; 2010 Jul 02; 285(27):20595-606. PubMed ID: 20442406
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ganglioside GM3 is required for caffeic acid phenethyl ester-induced megakaryocytic differentiation of human chronic myelogenous leukemia K562 cells.
    Jin UH, Chung TW, Song KH, Kwak CH, Choi HJ, Ha KT, Chang YC, Lee YC, Kim CH.
    Biochem Cell Biol; 2014 Aug 02; 92(4):243-9. PubMed ID: 24934090
    [Abstract] [Full Text] [Related]

  • 16. ZNF16 (HZF1) promotes erythropoiesis and megakaryocytopoiesis via regulation of the c-KIT gene.
    Chen J, Li XB, Su R, Song L, Wang F, Zhang JW.
    Biochem J; 2014 Feb 15; 458(1):171-83. PubMed ID: 24180487
    [Abstract] [Full Text] [Related]

  • 17. Differential expression changes in K562 cells during the hemin-induced erythroid differentiation and the phorbol myristate acetate (PMA)-induced megakaryocytic differentiation.
    Huo XF, Yu J, Peng H, Du ZW, Liu XL, Ma YN, Zhang X, Zhang Y, Zhao HL, Zhang JW.
    Mol Cell Biochem; 2006 Nov 15; 292(1-2):155-67. PubMed ID: 16786195
    [Abstract] [Full Text] [Related]

  • 18. Modulation of histidine decarboxylase activity and cytokine synthesis in human leukemic cell lines: relationship with basophilic and/or megakaryocytic differentiation.
    Dy M, Pacilio M, Arnould A, Machavoine F, Mayeux P, Hermine O, Bodger M, Schneider E.
    Exp Hematol; 1999 Aug 15; 27(8):1295-305. PubMed ID: 10428506
    [Abstract] [Full Text] [Related]

  • 19. ERK/MAPK pathway is required for changes of cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells.
    Lee CH, Yun HJ, Kang HS, Kim HD.
    IUBMB Life; 1999 Dec 15; 48(6):585-91. PubMed ID: 10683762
    [Abstract] [Full Text] [Related]

  • 20. Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that beta II protein kinase C is required for proliferation.
    Murray NR, Baumgardner GP, Burns DJ, Fields AP.
    J Biol Chem; 1993 Jul 25; 268(21):15847-53. PubMed ID: 8340409
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.